Renal abnormalities among children with sickle cell conditions in highly resource-limited setting in Ghana

Enoch Odame Anto1,2, Christian Obirikorang1, Emmanuel Acheampong1,2

  • 1Department of Molecular Medicine, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Plos One
|November 20, 2019
PubMed

Insights

Renal abnormalities like proteinuria and chronic kidney disease (CKD) are common in children with sickle cell disease (SCD), particularly Hb SS and Hb SC types. Routine kidney function monitoring is crucial for these children.

Area of Science:

  • Pediatric Nephrology
  • Hematology
  • Public Health

Background:

  • Sickle cell disease (SCD) is a genetic blood disorder linked to severe multi-organ damage, including the kidneys.
  • Early detection of renal abnormalities in children with SCD is vital for managing morbidity and mortality.

Purpose of the Study:

  • To investigate the prevalence of renal abnormalities in children diagnosed with sickle cell disease (SCD).
  • To identify associations between specific sickle cell genotypes (Hb AS, Hb SC, Hb SS) and renal health indicators.

Main Methods:

  • A cross-sectional study involving 212 children with SCD (Hb AS, Hb SC, Hb SS) in Ghana.
  • Analysis of urine and blood samples for urinalysis, serum urea, creatinine, and estimated glomerular filtration rate (eGFR).
  • Classification of chronic kidney disease (CKD) using KDIGO criteria.

Main Results:

  • The overall prevalence of renal abnormalities included proteinuria (26.4%) and CKD (39.6%).
  • Hb SS phenotype showed the highest prevalence of proteinuria (47.1%) and CKD (73.5%).
  • Children with Hb SS and Hb SC genotypes had significantly increased odds of developing CKD.

Conclusions:

  • Proteinuria and CKD are significantly associated with sickle cell disease, especially Hb SC and Hb SS genotypes.
  • Children with SCD are at a higher risk for renal complications.
  • Routine renal function monitoring is recommended for pediatric SCD patients.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
177
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
229
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
156
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
215
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
725
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
207